Prevalence of minimal disease activity in Australian patients with Psoriatic Arthritis: Assessing the outcome of national funding criteria for biologic disease-modifying antirheumatic drug prescribing.
Eliza K PontifexKokum DissanayakeDavid BursillTiffany GillPublished in: International journal of rheumatic diseases (2018)
The Australian PBS criteria, funding bDMARD prescribing for PsA, select well for MDA achievers. A high prevalence of MDA non-achievement remains in patients ineligible for bDMARD funding, and enthesitis in this population is more common. Inflammatory markers were not discriminators between treatment or MDA achievement groups.
Keyphrases
- rheumatoid arthritis
- disease activity
- breast cancer cells
- rheumatoid arthritis patients
- primary care
- systemic lupus erythematosus
- end stage renal disease
- juvenile idiopathic arthritis
- prostate cancer
- ankylosing spondylitis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- risk factors
- peritoneal dialysis
- emergency department
- quality improvement
- cell death
- combination therapy